OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Assessing the Effect of Selective Serotonin Reuptake Inhibitors in the Prevention of Post-Acute Sequelae of COVID-19
Hythem Sidky, David Sahner, Andrew T. Girvin, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 14

Showing 14 citing articles:

Depression and anxiety before and at the beginning of the COVID-19 pandemic and incident persistent symptoms: a prospective population-based cohort study
Joane Matta, Olivier Robineau, Emmanuel Wiernik, et al.
Molecular Psychiatry (2023) Vol. 28, Iss. 10, pp. 4261-4271
Closed Access | Times Cited: 29

The Relationship Between COVID-19 and the Development of Depression: Implications on Mental Health
Padmashri A Shetty, Lena Ayari, Jessica Madry, et al.
Neuroscience Insights (2023) Vol. 18
Open Access | Times Cited: 28

Treatment of 95 post-Covid patients with SSRIs
Carla P. Rus, Bert E. K. de Vries, Ingmar E. J. de Vries, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 25

Early treatment with fluvoxamine, bromhexine, cyproheptadine, and niclosamide to prevent clinical deterioration in patients with symptomatic COVID-19: a randomized clinical trial
Dhammika Leshan Wannigama, Cameron Hurst, Phatthranit Phattharapornjaroen, et al.
EClinicalMedicine (2024) Vol. 70, pp. 102517-102517
Open Access | Times Cited: 9

Overview of the potential use of fluvoxamine for COVID-19 and long COVID
Kenji Hashimoto
Discover Mental Health (2023) Vol. 3, Iss. 1
Open Access | Times Cited: 20

Association of severe mental illness and septic shock case fatality rate in patients admitted to the intensive care unit: A national population-based cohort study
Inès Lakbar, Marc Léone, Vanessa Pauly, et al.
PLoS Medicine (2023) Vol. 20, Iss. 3, pp. e1004202-e1004202
Open Access | Times Cited: 12

SSRI Use During Acute COVID-19 Infection Associated with Lower Risk of Long COVID Among Patients with Depression
Zachary Butzin-Dozier, Yunwen Ji, Sarang Deshpande, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 4

De-black-boxing health AI: demonstrating reproducible machine learning computable phenotypes using the N3C-RECOVER Long COVID model in the All of Us data repository
Emily Pfaff, Andrew T. Girvin, Miles Crosskey, et al.
Journal of the American Medical Informatics Association (2023) Vol. 30, Iss. 7, pp. 1305-1312
Open Access | Times Cited: 10

From intestinal metabolites to the brain: Investigating the mysteries of Long COVID
Shan Liu, Ashwarya S. Devason, Maayan Levy
Clinical and Translational Medicine (2024) Vol. 14, Iss. 3
Open Access | Times Cited: 1

SSRI use during acute COVID-19 and risk of long COVID among patients with depression
Zachary Butzin-Dozier, Yunwen Ji, Sarang Deshpande, et al.
BMC Medicine (2024) Vol. 22, Iss. 1
Open Access

Clinically Evaluated COVID-19 Drugs with Therapeutic Potential for Biological Warfare Agents
Ido-David Dechtman, Ran Ankory, Keren Sokolinsky, et al.
Microorganisms (2023) Vol. 11, Iss. 6, pp. 1577-1577
Open Access

Treatment and outcomes of 95 post-Covid patients with an antidepressant and neurobiological explanations
Carla C.P. Rus, Bert de Vries, Ingmar E. J. de Vries, et al.
Research Square (Research Square) (2023)
Open Access

Treatment of 95 post-Covid patients with SSRIs
Carla P. Rus, Bert E. K. de Vries, Ingmar E. J. de Vries, et al.
Research Square (Research Square) (2023)
Open Access

Page 1

Scroll to top